Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 3Carcinoma, Non-Small-Cell Lung 2Smoldering Multiple Myeloma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Nasopharyngeal Carcinoma 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1Carcinoma, Squamous Cell 1

Interventions

Tretinoin 12Arsenic Trioxide 7Methotrexate 5Mercaptopurine 5Cytarabine 5Idarubicin 4Mitoxantrone 3Thioguanine 2Radiotherapy 2Etoposide 2Daunorubicin 2Cyclophosphamide 2sargramostim 1merphos 1flt3 ligand protein 1Peripheral Blood Stem Cell Transplantation 1Maintenance 1Hydroxyurea 1Filgrastim 1Busulfan 1Amsacrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Promyelocytic, Acute × Maintenance × Clear all
NCT00599937 2008-01-24

APL93: Timing of CxT and Role of Maintenance

Groupe d'etude et de travail sur les leucemies aigues promyelocytaires

Phase 3 Completed
576 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡